Ocellatin-3N [D4K]

General Information


DRACP ID  DRACP04521

Peptide Name   Ocellatin-3N [D4K]

Sequence  GIFKVLKNLAKGVITSLAS

Sequence Length  19

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C91H159N23O24

Absent amino acids  CDEHMPQRWY

Common amino acids  KL

Mass  228066

Pl  11.1

Basic residues  3

Acidic residues  0

Hydrophobic residues  10

Net charge  3

Boman Index  850

Hydrophobicity  88.95

Aliphatic Index  143.68

Half Life 
  Mammalian:
  Yeast:
  E.coli:

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 36426386

Title  Antimicrobial, cytotoxic, and insulin-releasing activities of the amphibian host-defense peptide ocellatin-3N and its L-lysine-substituted analogs

Doi Not available

Year  2022

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  20347

DRACP is developed by Dr.Zheng's team.